Clinical trial
A Phase III Open, Multicentre Study to Investigate the Pharmacokinetics, Safety and Efficacy of BPL's High Purity Factor X in the Treatment of Severe and Moderate Factor X Deficiency.
NCT00930176 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Open, Multicentre Study to Investigate the Pharmacokinetics, Safety and Efficacy of BPL's High Purity Factor X in the Treatment of Severe and Moderate Factor X Deficiency.
- Lead sponsor
- Bio Products Laboratory
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- November 30, 2013
- Enrollment
- 16 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.